FTSV Key Statistics, Chart & Performance
The current stock price of FTSV is 95.51 null. In the past month the price increased by 1.03%. In the past year, price increased by 413.5%.
FTSV Latest News, Press Relases and Analysis
About FTSV
Company Profile
Forty Seven, Inc. is a clinical-stage immuno-oncology company. It focused on developing novel checkpoint therapies to activate macrophages in the fight against cancer. The company's product candidate consists of 5F9, is an IgG4 monoclonal antibody against CD47 which is designed to interfere with recognition of CD47 by the SIRP' receptor on macrophages. Forty Seven, Inc. is based in CA, United States.
Company Info
Forty Seven Inc
1490 O`BRIEN DRIVE SUITE A
MENLO PARK CA 94025
CEO: Mark A. McCamish
Phone: 650-352-4150
Forty Seven Inc / FTSV FAQ
What does FTSV do?
Forty Seven, Inc. is a clinical-stage immuno-oncology company. It focused on developing novel checkpoint therapies to activate macrophages in the fight against cancer. The company's product candidate consists of 5F9, is an IgG4 monoclonal antibody against CD47 which is designed to interfere with recognition of CD47 by the SIRP' receptor on macrophages. Forty Seven, Inc. is based in CA, United States.
What is the stock price of Forty Seven Inc today?
The current stock price of FTSV is 95.51 null. The price increased by 0.05% in the last trading session.
Does FTSV stock pay dividends?
FTSV does not pay a dividend.
What is the ChartMill technical and fundamental rating of FTSV stock?
FTSV has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
FTSV Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to FTSV. When comparing the yearly performance of all stocks, FTSV is one of the better performing stocks in the market, outperforming 99.78% of all stocks.
FTSV Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to FTSV. While FTSV has a great health rating, there are worries on its profitability.
FTSV Financial Highlights
Over the last trailing twelve months FTSV reported a non-GAAP Earnings per Share(EPS) of -2.34. The EPS increased by 37.6% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -558.88% | ||
| ROA | -25.5% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |